Array BioPharma (ARRY)

Add to Watchlists
Create an Alert
8.66 -0.05  -0.57% NASDAQ Dec 6, 20:00 Delayed 2m USD

Array BioPharma Net Income (Quarterly):

-28.61M for Sept. 30, 2016
View 4,000+ financial data types
Browse...
View Full Chart

Array BioPharma Net Income (Quarterly) Chart

Export Data
Save Image
Print Image

Array BioPharma Historical Net Income (Quarterly) Data

View and export this data going back to 2000. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2016 -28.61M
June 30, 2016 -25.01M
March 31, 2016 -22.68M
Dec. 31, 2015 -24.16M
Sept. 30, 2015 -20.99M
June 30, 2015 -12.73M
March 31, 2015 58.31M
Dec. 31, 2014 -8.611M
Sept. 30, 2014 -27.59M
June 30, 2014 -28.24M
March 31, 2014 -24.93M
Dec. 31, 2013 -16.41M
Sept. 30, 2013 -15.68M
June 30, 2013 -17.65M
March 31, 2013 -21.59M
Dec. 31, 2012 -10.93M
Sept. 30, 2012 -11.77M
June 30, 2012 -8.027M
March 31, 2012 -8.168M
Dec. 31, 2011 -3.803M
Sept. 30, 2011 -3.58M
June 30, 2011 -21.75M
March 31, 2011 -11.50M
Dec. 31, 2010 -12.44M
Sept. 30, 2010 -10.63M
   
June 30, 2010 -15.85M
March 31, 2010 -15.16M
Dec. 31, 2009 -21.82M
Sept. 30, 2009 -24.80M
June 30, 2009 -26.70M
March 31, 2009 -29.61M
Dec. 31, 2008 -37.82M
Sept. 30, 2008 -33.68M
June 30, 2008 -32.44M
March 31, 2008 -24.41M
Dec. 31, 2007 -20.39M
Sept. 30, 2007 -19.05M
June 30, 2007 -17.25M
March 31, 2007 -14.09M
Dec. 31, 2006 -15.87M
Sept. 30, 2006 -8.231M
June 30, 2006 -12.04M
March 31, 2006 -9.188M
Dec. 31, 2005 -8.711M
Sept. 30, 2005 -9.672M
June 30, 2005 -6.517M
March 31, 2005 -6.235M
Dec. 31, 2004 -4.877M
Sept. 30, 2004 -5.615M
June 30, 2004 -4.035M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Net Income

Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line. Net Income that is not paid out in dividends is added to retained earnings.

Increasing (decreasing) net income is a good (bad) sign for a company's profitability. Companies with consistent and increasing net income over time are looked at very favorably by stockholders.
Learn More

Advertisement

ARRY Net Income (Quarterly) Benchmarks

Companies
Pain Therapeutics -3.518M
Clovis Oncology -65.70M
Sarepta Therapeutics -56.74M

ARRY Net Income (Quarterly) Range, Past 5 Years

Minimum -28.61M Sep 2016
Maximum 58.31M Mar 2015
Average -13.96M

ARRY Net Income (Quarterly) Excel Add-In Codes

  • Metric Code: net_income
  • Latest data point: =YCP("ARRY", "net_income")
  • Last 5 data points: =YCS("ARRY", "net_income", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.